ppµç×Ó(ÖйúÇø)¹Ù·½ÍøÕ¾

¹«Ë¾ÐÂÎÅ

ÔÙÌíÐÂÆ· | ppµç×Ó(ÖйúÇø)¹Ù·½ÍøÕ¾»ùÒòºôÎüµÀºÏ°û²¡¶¾·ÖÐͲúÆ·»ñÅúÉÏÊÐ

ppµç×Ó(ÖйúÇø)¹Ù·½ÍøÕ¾ 2024.12.17

ÎÄÕÂȪԴ£ºÓ®Ïí·Ö×ÓÕï¶Ï¹«Öںţ¨ID£º  daangenescb£©

¿ËÈÕ£¬£¬£¬£¬£¬£¬£¬£¬ppµç×Ó(ÖйúÇø)¹Ù·½ÍøÕ¾»ùÒò×îÐÂÑÐÖÆµÄ¡°ºôÎüµÀºÏ°û²¡¶¾AÐͺÍBÐͺËËá¼ì²âÊÔ¼ÁºÐ£¨PCR-Ó«¹â̽Õë·¨£©¡±Í¨¹ý¹ú¼ÒÒ©¼à¾ÖµÄÈýÀàÒ½ÁÆÆ÷еע²áÉóÅú£¬£¬£¬£¬£¬£¬£¬£¬×¢²áÖ¤±àºÅ£º¹úеע׼20243402489¡£¡£¡£¡£¡£¡£¡£¡£
ppµç×Ó(ÖйúÇø)¹Ù·½ÍøÕ¾
±¾²úÆ·ÓÃÓÚ¶¨ÐÔ·ÖÐͼì²âÁÙ´²Ñù±¾ÖеĺôÎüµÀºÏ°û²¡¶¾AÐͺÍBÐÍRNA£¬£¬£¬£¬£¬£¬£¬£¬¼ì²âЧ¹û¿ÉΪ²¡ÀýÈ·Õï¡¢ÖÎÁÆÓÃÒ©¡¢ÐͱðÅжϡ¢Ê¢Ðмà²âÌṩ׼ȷµÄ²¡Ô­Ñ§¼ì²âÒÀ¾Ý¡£¡£¡£¡£¡£¡£¡£¡£


HRSVÊÇ×îÖ÷ÒªµÄºôÎüµÀ²¡Ô­Ö®Ò»

È˺ôÎüµÀºÏ°û²¡¶¾£¨HRSV£©ÊÇÒýÆð5ËêÒÔ϶ùͯ¡¢ÍíÄêÈ˼°ÃâÒßµÍÏÂÈËȺ¼±ÐÔϺôÎüµÀѬȾ×îÖ÷ÒªµÄ²¡¶¾²¡Ô­Ö®Ò»¡£¡£¡£¡£¡£¡£¡£¡£¾Ý¡¶ÁøÒ¶µ¶¡·±¨¸æ£¬£¬£¬£¬£¬£¬£¬£¬2019ÄêÈ«Çò5ËêÒÔ϶ùͯÖÐÔ¼ÓÐ3300ÍòÀýHRSVÏà¹Ø¼±ÐÔϺôÎüµÀѬȾ²¡Àý£¬£¬£¬£¬£¬£¬£¬£¬ÆäÖаüÀ¨Ô¼360ÍòסԺ²¡ÀýºÍÔ¼10ÍòéæÃü²¡Àý¡£¡£¡£¡£¡£¡£¡£¡£

 

HRSVÖ»ÓÐÒ»¸öѪÇåÐÍ£¬£¬£¬£¬£¬£¬£¬£¬·ÖΪA¡¢BÁ½¸öÑÇÐÍ¡£¡£¡£¡£¡£¡£¡£¡£¹ú¼ÊÉÏÒÀ¾ÝG»ùÒòµÚ¶þ¸ß±äÇøµÄ»ùÒò±äÒ콫HRSV»®·ÖΪ²î±ð»ùÒòÐÍ£¬£¬£¬£¬£¬£¬£¬£¬ÏÖÔÚÒÑÅжϳö59¸ö»ùÒòÐÍ£¬£¬£¬£¬£¬£¬£¬£¬ÆäÖÐHRSV-AÑÇÐÍ·ÖΪ22¸ö»ùÒòÐÍ£¬£¬£¬£¬£¬£¬£¬£¬HRSV-BÑÇÐÍ·ÖΪ37¸ö»ùÒòÐÍ¡£¡£¡£¡£¡£¡£¡£¡£AÑÇÐ͵ÄON1»ùÒòÐͺÍBÑÇÐ͵ÄBA9»ùÒòÐÍÊÇÏÖÔÚÈ«ÇòÊ¢ÐеÄÓÅÊÆ»ùÒòÐÍ£¬£¬£¬£¬£¬£¬£¬£¬Ò²ÊÇÎÒ¹ú½üÄêÊ¢ÐеÄÖ÷Òª»ùÒòÐÍ¡£¡£¡£¡£¡£¡£¡£¡£

 

2010-2020ÄêÖйú·¢ÈȺôÎüµÀÖ¢ºòȺ²¡Àý¼à²âÊý¾ÝÏÔʾ£¬£¬£¬£¬£¬£¬£¬£¬HRSV×ܼì³öÂÊΪ7.2%¡£¡£¡£¡£¡£¡£¡£¡£HRSV¶¾Öê·ÖÐÍÇéÐÎÏÔʾ£¬£¬£¬£¬£¬£¬£¬£¬´¿´âAÐͶ¾ÖêѬȾ²¡ÀýÕ¼59.1%£¬£¬£¬£¬£¬£¬£¬£¬´¿´âBÐͶ¾ÖêѬȾ²¡ÀýÕ¼39.6%£¬£¬£¬£¬£¬£¬£¬£¬A/BÐͶ¾Öê»ìÏýѬȾ²¡ÀýÕ¼1.3%£¬£¬£¬£¬£¬£¬£¬£¬²î±ðÄê·Ý¼äHRSV¶¾ÖêÑÇÐͱ£´æ¾ÞϸÄê½»ÌæÊ¢ÐС£¡£¡£¡£¡£¡£¡£¡£


ppµç×Ó(ÖйúÇø)¹Ù·½ÍøÕ¾

2010-2020ÄêÖйú²î±ðÄê·Ý·¢ÈȺôÎüµÀÖ¢ºòȺ²¡Àý

È˺ôÎüµÀºÏ°û²¡¶¾µÄ¼ì³öÇéÐÎÓëÑÇÐÍÂþÑÜ

 

 


HRSVѬȾµÄÁÙ´²ÌåÏÖ¼°ÑÇÐͲî±ð

HRSVѬȾºó£¬£¬£¬£¬£¬£¬£¬£¬Ç±ÔÚÆÚͨ³£Îª2-8Ì죬£¬£¬£¬£¬£¬£¬£¬ÁÙ´²ÌåÏÖÒÔºôÎüµÀ֢״ΪÖ÷¡£¡£¡£¡£¡£¡£¡£¡£Ñ¬È¾ÔçÆÚÖ¢×´¶à¾ÖÏÞÓÚÉϺôÎüµÀ£¬£¬£¬£¬£¬£¬£¬£¬Èç±ÇÈû¡¢Á÷Ìé¡¢¿ÈËÔºÍÉùÒôË»ÑÆµÈ£¬£¬£¬£¬£¬£¬£¬£¬´ó¶¼Ö¢×´»áÔÚ1-2ÖÜÄÚ×ÔÐÐÏûÊÅ¡£¡£¡£¡£¡£¡£¡£¡£ÉÙÊý¿ÉÉú³¤ÎªÏºôÎüµÀÖ¢×´£¬£¬£¬£¬£¬£¬£¬£¬Ö÷ÒªÎªÃ«Ï¸Ö§Æø¹ÜÑ×»ò·ÎÑ×£¬£¬£¬£¬£¬£¬£¬£¬¶à¼ûÓÚ2ËêÒÔÏÂÓ¤Ó×¶ù¡£¡£¡£¡£¡£¡£¡£¡£ÉÙÉÙÊý½øÒ»²½¼ÓÖØÎªºôÎü¼±´Ù£¬£¬£¬£¬£¬£¬£¬£¬ÑÏÖØÕß¿ÉÉú³¤ÎªºôÎüË¥½ß£¬£¬£¬£¬£¬£¬£¬£¬ÉõÖÁéæÃü¡£¡£¡£¡£¡£¡£¡£¡£

 

¶ÔHRSV¶¾Öê¾ÙÐÐÐͱðÅжϺͼà²â£¬£¬£¬£¬£¬£¬£¬£¬ÓÐÖúÓÚÏàʶÐͱðÓë¼²²¡ÌåÏÖµÄÏà¹ØÐÔ£¬£¬£¬£¬£¬£¬£¬£¬Í¬Ê±¿ÉΪҩÎïºÍÒßÃçµÄÑÐÖÆ¡¢Ò©ÎïºÍÒßÃçЧ¹ûÆÀ¹ÀÌṩÖ÷ÒªµÄ¿ÆÑ§ÒÀ¾Ý¡£¡£¡£¡£¡£¡£¡£¡£

¡ñ ¹ãÖÝÒ½¿Æ´óѧÁ¥ÊôµÚÒ»Ò½ÔºµÄÒ»ÏîΪÆÚ3ÄêµÄ²¡ÀýÑо¿£¬£¬£¬£¬£¬£¬£¬£¬¶Ô645ÀýHRSVÑôÐÔ»¼¶ùµÄÁÙ´²ÌåÏÖ¾ÙÐÐÁËÆÊÎö£¬£¬£¬£¬£¬£¬£¬£¬HRSV-AÐͱÈHRSV-BÐ͸üÈÝÒ×±¬·¢Ã«Ï¸Ö§Æø¹ÜÑס¢ºôÎüÄÑÌâ¡¢±ÇÑס¢ÍÂÄæ¡¢Ê³Óû²»ÕñºÍ¸¹Ðº£¬£¬£¬£¬£¬£¬£¬£¬¶øHRSV-BÐͱÈHRSV-AÐ͸üÈÝÒ×·ºÆðº®Õ½¡¢Í·Í´¡¢¼¡Í´¡¢ÐéÈõºÍƤÕîµÈ£¬£¬£¬£¬£¬£¬£¬£¬Ð§¹ûÌáÐÑHRSV-AÐͺÍHRSV-BÐ;ßÓÐÌØÒìÐÔµÄÁÙ´²ÌØÕ÷¡£¡£¡£¡£¡£¡£¡£¡£

¡ñ ÃÀ¹úµÄÒ»ÏîÕë¶Ô5ËêÒÔ϶ùͯµÄ¶àÖÐÐÄǰհÐÔ¼à²âÑо¿ÏÔʾ£¬£¬£¬£¬£¬£¬£¬£¬ÔÚ5ËêÒÔ϶ùͯºÍ1ËêÒÔ϶ùͯÖУ¬£¬£¬£¬£¬£¬£¬£¬HRSV-AÐͱÈHRSV-BÐ͵ÄסԺ¼¸Âʸü¸ß£¨5ËêÒÔ϶ùͯ£ºaOR = 1.28£» £»£»£»£»£»95% CI = [1.14-1.44]£» £»£»£»£»£»P < .001£» £»£»£»£»£»1ËêÒÔ϶ùͯ£ºaOR = 1.29£» £»£»£»£»£»95% CI = [1.09-1.51]£» £»£»£»£»£»P = .002£©£¬£¬£¬£¬£¬£¬£¬£¬ÔÚ5ËêÒÔ϶ùͯÖУ¬£¬£¬£¬£¬£¬£¬£¬HRSV-AÐͱÈHRSV-BÐ͵ĽÓÊÜÑõÆøÖ§³ÖµÄ¼¸ÂÊÒ²¸ü¸ß£¨aOR = 1.17£» £»£»£»£»£»95% CI = [1.02-1.34]£» £»£»£»£»£»P = .023£©¡£¡£¡£¡£¡£¡£¡£¡£

¡ñ °Ä´óÀûÑǵÄÒ»ÏîΪÆÚ5ÄêµÄµ¥ÖÐÐÄ»ØÊ×ÐÔÑо¿ÏÔʾ£¬£¬£¬£¬£¬£¬£¬£¬Ïà±ÈHRSV-AÐÍ£¬£¬£¬£¬£¬£¬£¬£¬ºôÎüµÀ»ìÏýѬȾÔÚHRSV-BÐÍÖиü³£¼û£¨41.8% vs. 27.4%£¬£¬£¬£¬£¬£¬£¬£¬P = 0.035£©£¬£¬£¬£¬£¬£¬£¬£¬½ø¶øµ¼ÖÂHRSV-BÐ͵ÄICUסԺʱ¼ä¸ü³¤£¨5Ìì vs. 3Ì죬£¬£¬£¬£¬£¬£¬£¬P = 0.006£©¡£¡£¡£¡£¡£¡£¡£¡£

 

ȨÍþÍÆ¼ö

ºËËá¼ì²âµÄÃô¸ÐÐÔºÍÌØÒìÐԸߣ¬£¬£¬£¬£¬£¬£¬£¬¹ØÓÚÓкËËá¼ì²âÌõ¼þµÄÒ½Ôº£¬£¬£¬£¬£¬£¬£¬£¬Ö¸ÄÏÍÆ¼ö¿ÉÖ±½Ó¾ÙÐкËËá¼ì²âÓÃÓÚHRSVѬȾÕï¶Ï¡£¡£¡£¡£¡£¡£¡£¡£

¡ñ¡¶Öйú¶ùͯºôÎüµÀºÏ°û²¡¶¾Ñ¬È¾ÕïÁƼ°Ô¤·ÀÖ¸ÄÏ£¨2024Ò½Éú°æ£©¡·

 

ÍÆ¼öÒâ¼û2£ººËËá¼ì²âÊÊÓÃÓÚ¸÷¼¶Ò½ÔºÃÅÕïºÍ¼±Õ£¬£¬£¬£¬£¬£¬£¬ÓкËËá¼ì²âÌõ¼þµÄÒ½Ôº¿ÉÒÔÖ±½Ó¾ÙÐкËËá¼ì²â£» £»£»£»£»£»¶àÖØºËËá¼ì²âÒªÁìÊÊÓÃÓÚסԺ»¼¶ùÈëԺǰÒÔ¼°×¡ÔººóµÄ¼ì²â£» £»£»£»£»£»²»ÍƼöÓ¦Óöþ´ú²âÐò×÷ΪÁÙ´²Í¨Àý¼ì²â£¨Ç¿ÍƼö£¬£¬£¬£¬£¬£¬£¬£¬¸ßÖ¤¾ÝÖÊÁ¿£©¡£¡£¡£¡£¡£¡£¡£¡£

 

 

 

 

 

 

 

 

 

 

 

 

 

 

¡ñ¡¶È˺ôÎüµÀºÏ°û²¡¶¾Ñ¬È¾Õï¶Ï£¨CT/CPMA 028-2023£©¡·

 

ƾ֤ʢÐв¡Ñ§¡¢ÁÙ´²ÌåÏÖºÍʵÑéÊÒ¼ì²âЧ¹û¾ÙÐÐÕï¶Ï¡£¡£¡£¡£¡£¡£¡£¡£ÓÐÊ¢Ðв¡Ñ§Ê·ºÍHRSVѬȾÁÙ´²ÌåÏֵIJ¡Àý£¬£¬£¬£¬£¬£¬£¬£¬ºôÎüµÀ±ê±¾Öмì²âHRSVºËËáÑôÐÔ¿ÉÈ·Õï¡£¡£¡£¡£¡£¡£¡£¡£

 

 

 

 

 

 

 

 

 

 

 

 

 

 

¡ñ¡¶¶ùͯºôÎüµÀºÏ°û²¡¶¾Ñ¬È¾ÁÙ´²ÕïÖÎÖйúר¼Ò¹²Ê¶£¨2023Äê°æ£©¡·

 

½¨Òé3£¨¹²Ê¶Ë®Æ½£º96%£©£ººËËá¼ì²âѸËٶȸߡ¢ÌØÒìÐԸߡ¢¼ì²âÖÜÆÚ¶Ì£¬£¬£¬£¬£¬£¬£¬£¬ÊÇÁÙ´²É϶ùͯRSVѬȾ²¡Ô­Ñ§Õï¶ÏµÄÖ÷Á÷ÒªÁì¡£¡£¡£¡£¡£¡£¡£¡£

 

 

¶¬´º¼¾ÊǺôÎüµÀѬȾ²¡µÄ¸ß·¢¼¾½Ú£¬£¬£¬£¬£¬£¬£¬£¬Ëæ×ÅÆøÎÂÖð½¥Ï½µ£¬£¬£¬£¬£¬£¬£¬£¬¼±ÐÔºôÎüµÀѬȾ²¡·ºÆðÖð½¥ÉÏÉýÇ÷ÊÆ¡£¡£¡£¡£¡£¡£¡£¡£Ììϼ±ÐÔºôÎüµÀѬȾ²¡ÉÚµã¼à²âÇéÐΣ¨2024ÄêµÚ49ÖÜ£©£ºÁ÷¸Ð²¡¶¾ÑôÐÔÂʽüÆÚÉÏÉýÇ÷ÊÆÏÔ×Å£» £»£»£»£»£»±Ç²¡¶¾Ñ¬È¾ÔÚÊ¢ÐÐÆÚ²¨¶¯£¬£¬£¬£¬£¬£¬£¬£¬µ«³ÊϽµÇ÷ÊÆ£» £»£»£»£»£»±±·½Ê¡·Ý·ÎÑ×Ö§Ô­ÌåÑôÐÔÂʲ¨¶¯Ï½µ£¬£¬£¬£¬£¬£¬£¬£¬ÄÏ·½Ê¡·Ý·ÎÑ×Ö§Ô­ÌåѬȾÈÔ´¦ÓڽϵÍˮƽ£¬£¬£¬£¬£¬£¬£¬£¬·ÎÑ×Ö§Ô­ÌåѬȾÖ÷ÒªÊÜÓ°ÏìµÄÈËȺÊÇ5~14ËêѧÁä¶ùͯ£» £»£»£»£»£»0~4Ë겡ÀýÖеĺôÎüµÀºÏ°û²¡¶¾ÑôÐÔÂÊ¡¢ÒÔ¼°14Ëê¼°ÒÔϲ¡ÀýÖÐÈËÆ«·Î²¡¶¾ÑôÐÔÂʽüÆÚ³Ê²¨¶¯ÉÏÉýÇ÷ÊÆ£¬£¬£¬£¬£¬£¬£¬£¬±±·½Ê¡·ÝÉÏÉýÇ÷ÊÆ¸üÏÔ×Å£» £»£»£»£»£»ÏÙ²¡¶¾Ñ¬È¾ÔÚÒ»¶¨Ë®Æ½²¨¶¯¡£¡£¡£¡£¡£¡£¡£¡£

 

²î±ðµØÇøºÍ²î±ðÄêËê¶ÎÈËȺµÄÖ÷ҪʢÐв¡Ô­Ìå±£´æ²î±ð¡£¡£¡£¡£¡£¡£¡£¡£

µÚ49ÖܺôÎüµÀÑù±¾Ö÷Òª²¡Ô­ÌåºËËá¼ì²âÑôÐÔÂÊÇøÓò²î±ð
ppµç×Ó(ÖйúÇø)¹Ù·½ÍøÕ¾

µÚ49ÖܺôÎüµÀÑù±¾Ö÷Òª²¡Ô­ÌåºËËá¼ì²âÑôÐÔÂÊÄêËê×é²î±ð
ppµç×Ó(ÖйúÇø)¹Ù·½ÍøÕ¾

 

ΪÁËÖúÁ¦¸÷¼¶Ò½ÁÆ»ú¹¹ºôÎüµÀѬȾ²¡¾«×¼ÕïÁÆÄÜÁ¦ÌáÉý£¬£¬£¬£¬£¬£¬£¬£¬ppµç×Ó(ÖйúÇø)¹Ù·½ÍøÕ¾»ùÒòÍÆ³ö¡°ÖÜÈ«¡¢ÎÞа¡¢¸ßЧ¡¢¾­¼Ã¡±µÄºôÎüµÀ²¡Ô­ÌåºËËá¼ì²âÕûÌå½â¾ö¼Æ»®£¬£¬£¬£¬£¬£¬£¬£¬Ò½ÁÆ»ú¹¹¿Éƾ֤ÍâµØÇøµÄºôÎüµÀ²¡Ô­Ê¢ÐÐÇéÐΣ¬£¬£¬£¬£¬£¬£¬£¬ÎÞаѡÔñ¾ÙÐÐÕë¶ÔÐÔµ¥¼ì»ò×éºÏ¼ì²â£¬£¬£¬£¬£¬£¬£¬£¬¼ÈÖª×ãÁÙ´²ÕïÁÆÐèÇó¡¢ÓÖºÏÀí¿ØÖÆÒ½ÁÆÓöÈ¡£¡£¡£¡£¡£¡£¡£¡£

ppµç×Ó(ÖйúÇø)¹Ù·½ÍøÕ¾

 

²Î¿¼ÎÄÏ×£º

[1] Li Y, Wang X, Blau DM, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022;399(10340):2047-2064.

[2] ÖйúÒ½Ò©½ÌÓýЭ»á¶ù¿Æ×¨ÒµÎ¯Ô±»á£¬£¬£¬£¬£¬£¬£¬£¬ÖлªÒ½Ñ§»á¶ù¿ÆÑ§·Ö»áºôÎüѧ×飬£¬£¬£¬£¬£¬£¬£¬ÖйúҽʦЭ»áºôÎüҽʦ·Ö»á¶ù¿ÆºôÎüÊÂÇéίԱ»á,µÈ. Öйú¶ùͯºôÎüµÀºÏ°û²¡¶¾Ñ¬È¾ÕïÁƼ°Ô¤·ÀÖ¸ÄÏ(2024Ò½Éú°æ). ÖлªÊÊÓöù¿ÆÁÙ´²ÔÓÖ¾£¬£¬£¬£¬£¬£¬£¬£¬2024£¬£¬£¬£¬£¬£¬£¬£¬39(10):723-732.

[3] Àî°ØËÉ£¬£¬£¬£¬£¬£¬£¬£¬Ê¦Ô㬣¬£¬£¬£¬£¬£¬£¬¹¢ÃνÜ,µÈ. 2010—2020ÄêÖйú·¢ÈȺôÎüµÀÖ¢ºòȺ²¡ÀýÖÐÈ˺ôÎüµÀºÏ°û²¡¶¾µÄÊ¢ÐÐÌØÕ÷ÆÊÎö. ÖлªÔ¤·ÀҽѧÔÓÖ¾£¬£¬£¬£¬£¬£¬£¬£¬2024£¬£¬£¬£¬£¬£¬£¬£¬58(09):1311-1317.

[4] Liu W, Chen D, Tan W, et al. Epidemiology and Clinical Presentations of Respiratory Syncytial Virus Subgroups A and B Detected with Multiplex Real-Time PCR. PLoS One. 2016;11(10):e0165108.

[5] Toepfer AP, Amarin JZ, Spieker AJ, et al. Seasonality, Clinical Characteristics, and Outcomes of Respiratory Syncytial Virus Disease by Subtype Among Children Aged <5 Years: New Vaccine Surveillance Network, United States, 2016-2020. Clin Infect Dis. 2024;78(5):1352-1359.

[6] Saravanos GL, Ramos I, Britton PN, Wood NJ. Respiratory syncytial virus subtype circulation and associated disease severity at an Australian paediatric referral hospital, 2014-2018. J Paediatr Child Health. 2021;57(8):1190-1195.

[7] ÖлªÔ¤·Àҽѧ»á. È˺ôÎüµÀºÏ°û²¡¶¾Ñ¬È¾Õï¶Ï£¨CT/CPMA 028-2023£©. ÖлªÔ¤·ÀҽѧÔÓÖ¾£¬£¬£¬£¬£¬£¬£¬£¬2023£¬£¬£¬£¬£¬£¬£¬£¬57(07):961-967.

[8] ¶ùͯºôÎüµÀºÏ°û²¡¶¾Ñ¬È¾ÁÙ´²ÕïÖÎÖйúר¼Ò¹²Ê¶£¨2023Äê°æ£©[J].ÁÙ´²¶ù¿ÆÔÓÖ¾,2024,42(01):1-14.

 

 








 
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿